DK1478780T3 - Fremgangsmåde til in vitro-detektion af cancer ved påvisning af alleliske uligevægte i markörer for indsættelse-deletion - Google Patents

Fremgangsmåde til in vitro-detektion af cancer ved påvisning af alleliske uligevægte i markörer for indsættelse-deletion

Info

Publication number
DK1478780T3
DK1478780T3 DK03722673T DK03722673T DK1478780T3 DK 1478780 T3 DK1478780 T3 DK 1478780T3 DK 03722673 T DK03722673 T DK 03722673T DK 03722673 T DK03722673 T DK 03722673T DK 1478780 T3 DK1478780 T3 DK 1478780T3
Authority
DK
Denmark
Prior art keywords
detection
markers
cancer
allelic imbalances
insertion deletion
Prior art date
Application number
DK03722673T
Other languages
English (en)
Inventor
Bernard Grandchamp
France Mentre
Original Assignee
Assist Publ Hopitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publ Hopitaux De Paris filed Critical Assist Publ Hopitaux De Paris
Application granted granted Critical
Publication of DK1478780T3 publication Critical patent/DK1478780T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DK03722673T 2002-02-25 2003-02-25 Fremgangsmåde til in vitro-detektion af cancer ved påvisning af alleliske uligevægte i markörer for indsættelse-deletion DK1478780T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0202380A FR2836484B1 (fr) 2002-02-25 2002-02-25 Procede de detection in vitro des cancers par la mise en evidence de desequilibres alleliques de marqueurs d'insertion-deletion
PCT/FR2003/000609 WO2003072823A2 (fr) 2002-02-25 2003-02-25 Procede de detection in vitro des cancers par la mise en evidence de desequilibres alleliques de marqueurs d'insertion-deletion

Publications (1)

Publication Number Publication Date
DK1478780T3 true DK1478780T3 (da) 2008-05-13

Family

ID=27676062

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03722673T DK1478780T3 (da) 2002-02-25 2003-02-25 Fremgangsmåde til in vitro-detektion af cancer ved påvisning af alleliske uligevægte i markörer for indsættelse-deletion

Country Status (11)

Country Link
EP (2) EP1478780B1 (da)
AT (1) ATE383443T1 (da)
AU (1) AU2003229840A1 (da)
CA (1) CA2475680C (da)
CY (1) CY1107364T1 (da)
DE (1) DE60318552T2 (da)
DK (1) DK1478780T3 (da)
ES (1) ES2299697T3 (da)
FR (1) FR2836484B1 (da)
PT (1) PT1478780E (da)
WO (1) WO2003072823A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2113574A1 (en) * 2008-04-28 2009-11-04 Biotype AG Substances and methods for a DNA based profiling assay

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731294A (en) * 1993-07-27 1998-03-24 Hybridon, Inc. Inhibition of neovasularization using VEGF-specific oligonucleotides
US6051374A (en) * 1994-02-14 2000-04-18 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6479235B1 (en) * 1994-09-30 2002-11-12 Promega Corporation Multiplex amplification of short tandem repeat loci
CA2275865C (en) * 1996-08-28 2006-12-12 The Johns Hopkins University School Of Medicine Method for detecting cell proliferative disorders
AU1085401A (en) * 1999-10-15 2001-04-30 Orchid Biosciences, Inc. Genotyping reagents, kits and methods of use thereof
MXPA02004482A (es) * 1999-11-05 2002-10-11 Pioneer Hi Bred Int Genes que codifican enzimas para la biosintesis de lignina y usos de los mismos.
CA2395926A1 (en) * 1999-12-28 2001-07-05 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof

Also Published As

Publication number Publication date
WO2003072823A3 (fr) 2004-04-08
ES2299697T3 (es) 2008-06-01
CA2475680A1 (fr) 2003-09-04
DE60318552D1 (de) 2008-02-21
DE60318552T2 (de) 2009-03-26
FR2836484B1 (fr) 2005-02-04
CA2475680C (fr) 2013-10-01
EP1478780B1 (fr) 2008-01-09
CY1107364T1 (el) 2012-12-19
AU2003229840A1 (en) 2003-09-09
FR2836484A1 (fr) 2003-08-29
WO2003072823A2 (fr) 2003-09-04
PT1478780E (pt) 2008-04-16
EP1478780A2 (fr) 2004-11-24
EP1914648A1 (fr) 2008-04-23
ATE383443T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
Hegemann et al. Liquid biopsy: ready to guide therapy in advanced prostate cancer?
Ahmed et al. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle
Nikiforova et al. Molecular diagnostics of gliomas
DK1871912T3 (da) Fremgangsmåde til bestemmelse af DNA-methylering i blod- eller urinprøver
NZ593227A (en) Gene expression markers (MYBL2) for colorectal cancer prognosis
WO2005116257A3 (en) Unique short tandem repeats and methods of their use
WO2005098050A3 (en) Base specific cleavage of methylation-specific amplification products in combination with mass analysis
IS6887A (is) Aðferð til að greina sýtósín metýleringarmynstur sem hafa mikla næmni
WO2011070441A3 (en) Categorization of dna samples
WO2006017083A3 (en) Methods and compositions for phenotype identification based on nucleic acid methylation
WO2006076017A3 (en) Methods and kits for identifying target nucleotides in mixed populations
WO2004097052A3 (en) Methods for prognosis and treatment of solid tumors
DK1290444T3 (da) Toxicitetstypisering under anvendelse af lever-stamceller
Qian et al. Aberrant methylation of the death‐associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia
CR9100A (es) Metodos y sistemas para el pronostico y tratamiento de tumores solidos
DK1723256T3 (da) CpG-Amplikon og array-kontrol
WO2003027638A8 (en) Methods for detecting genetic mosaicisms using arrays
Takeuchi et al. Downregulation of expression of a novel cadherin molecule, T‐cadherin, in basal cell carcinoma of the skin
AU2020336115A1 (en) Characterizing methylated DNA, RNA, and proteins in subjects suspected of having lung neoplasia
DK2210954T3 (da) Bestemmelse af DNA-methyleringsniveau
WO2006039673A3 (en) Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles
Qu et al. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials
Li et al. Investigation of epigenetics in kidney cell biology
DK1478780T3 (da) Fremgangsmåde til in vitro-detektion af cancer ved påvisning af alleliske uligevægte i markörer for indsættelse-deletion
Qin et al. Advances in single-cell sequencing technology in the field of hepatocellular carcinoma